December 4, 2025 Uncategorized BetterLife Pharma Highlights Advantages of BETR-001 – a Potent Neuroplastogen Read More
November 25, 2025 Uncategorized BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor Read More
October 21, 2025 Uncategorized BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor Read More
June 18, 2025 Uncategorized USPTO Files ISSUE NOTIFICATION for BetterLife’s BETR-001 Composition of Matter Patent Read More
May 28, 2025 Uncategorized BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001 Read More
May 14, 2025 Uncategorized BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders Read More
January 14, 2025 Uncategorized USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent Read More
